| PARTNER-PHARMACIES |
PARTNER-PHARMACIES |
90%
|
The Company accounts for prescription product revenue from Partner Pharmacies as a principal in the arrangement with its customers. |
| ADDITIONALLY-APOSTROPHE-PHARMACY-LLC |
ADDITIONALLY-APOSTROPHE-PHARMACY-LLC |
85%
|
health providers; collectively referred to as “Providers” or individually, a “Provider”) to provide consultation services. We determined that we are the primary beneficiary of the Affiliated Medical … |
| PLATFORM-PARTNERS |
PLATFORM-PARTNERS |
85%
|
Further, to provide access to certain products, a substantial majority of which are prescription products, the Company has contracts with third-party platform partners ("Platform Partners"). |
| WHOLESALE-PARTNERS |
WHOLESALE-PARTNERS |
75%
|
Additionally, in the United States, the Company offers a range of health and wellness products through wholesale partners, with such revenue not considered significant. |
| NVO |
Novo Nordisk A/S |
72%
|
of the principal amount of converted 2030 Convertible Notes, with such reduction and/or offsets subject to a cap based on the cap price. The Capped Calls cover, subject to anti-dilution adjustments s… |
| NVO |
Novo Nordisk A/S |
72%
|
Reciprocal relationship from NVO graph: Reciprocal relationship from HIMS graph: Reciprocal relationship from NVO graph: Reciprocal relationship from HIMS graph: Reciprocal relationship from NVO grap… |
| AFFILIATED-MEDICAL-GROUP |
AFFILIATED-MEDICAL-GROUP |
62%
|
omer requirements could be materially impaired or interrupted in the event that our relationship with an Affiliated Medical Group, Facility, Partner Pharmacy or Manufacturing Supplier is terminated, … |
| APOSTROPHE-PHARMACY-LLC |
APOSTROPHE-PHARMACY-LLC |
62%
|
opened an approximately 300,000 square foot facility in New Albany, Ohio. In 2021, this facility began housing a dedicated licensed mail order pharmacy, XeCare, LLC (or “XeCare”), that provides presc… |
| BLACKFLY-INVESTMENTS-LLC |
BLACKFLY-INVESTMENTS-LLC |
62%
|
e or approval, including a warning letter to Blackfly Investments, LLC d/b/a Molecular Testing Labs, in which FDA stated that an HIV dried blood-spot self-collection kit was being offered without the… |
| CHIEF-EXECUTIVE-OFFICER-CO |
CHIEF-EXECUTIVE-OFFICER-CO |
62%
|
ith retroactive effect) and could be applied solely or disproportionately to services provided over the internet or could otherwise materially affect our financial position and results of operations.… |
| DELAWARE-GENERAL-CORPORATION |
DELAWARE-GENERAL-CORPORATION |
62%
|
ith retroactive effect) and could be applied solely or disproportionately to services provided over the internet or could otherwise materially affect our financial position and results of operations.… |
| EHT-PHARMACY-LLC |
EHT-PHARMACY-LLC |
62%
|
ine. We are the exclusive administrative services provider for the Affiliated Medical Groups, and the Affiliated Medical Groups provide services to patients exclusively through the Hims & Hers platfo… |
| HERS-HEALTH-INC |
HERS-HEALTH-INC |
62%
|
Item 1A: “Risk Factors” may not be exhaustive. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may no… |
| HERS-UK-LIMITED |
HERS-UK-LIMITED |
62%
|
gital-first, cloud-based business model has driven rapid adoption in the U.S. Additionally, our model has been developed to be scalable and applicable across new markets and languages. We expanded in… |
| H-H-GERMANY-GMBH |
H-H-GERMANY-GMBH |
62%
|
y pressures or the impact of trade actions may affect the ability of our Subscribers to continue to pay for our products and services, which may also impact the future results of our operations. Inve… |
| HONEST-HEALTH-LIMITED |
HONEST-HEALTH-LIMITED |
62%
|
ich were strategically priced to attract new customers. The decrease was partially offset by lower costs associated with medical consultation services as a percent of revenue as a result of improving… |
| MEDICAL-GROUP |
MEDICAL-GROUP |
62%
|
iated Medical Group and Provider provides the consultation to the customer; (ii) the Company is primarily responsible for the satisfactory fulfillment and acceptability of the services; (iii) the Com… |
| MEDICI-TECHNOLOGIES-INC |
MEDICI-TECHNOLOGIES-INC |
62%
|
y pressures or the impact of trade actions may affect the ability of our Subscribers to continue to pay for our products and services, which may also impact the future results of our operations. Inve… |
| NOV |
NOV Inc. |
62%
|
Reciprocal relationship from NOV graph: Reciprocal relationship from HIMS graph: of the principal amount of converted 2030 Convertible Notes, with such reduction and/or offsets subject to a cap based… |
| NOVO-NORDISK-INC |
NOVO-NORDISK-INC |
62%
|
of the principal amount of converted 2030 Convertible Notes, with such reduction and/or offsets subject to a cap based on the cap price. The Capped Calls cover, subject to anti-dilution adjustments s… |
| SEAVIEW-ENTERPRISES-LLC |
SEAVIEW-ENTERPRISES-LLC |
62%
|
opened an approximately 300,000 square foot facility in New Albany, Ohio. In 2021, this facility began housing a dedicated licensed mail order pharmacy, XeCare, LLC (or “XeCare”), that provides presc… |
| SIGMUND-NJ-LLC |
SIGMUND-NJ-LLC |
62%
|
opened an approximately 300,000 square foot facility in New Albany, Ohio. In 2021, this facility began housing a dedicated licensed mail order pharmacy, XeCare, LLC (or “XeCare”), that provides presc… |
| U-K-BASED-HONEST-HEALTH-LIMITED |
U-K-BASED-HONEST-HEALTH-LIMITED |
62%
|
gital-first, cloud-based business model has driven rapid adoption in the U.S. Additionally, our model has been developed to be scalable and applicable across new markets and languages. We expanded in… |
| WOOLLY-LABS-INC |
WOOLLY-LABS-INC |
62%
|
f these shares have been forfeited. The total grant date fair value of the awards was $ 0.4 million, which was based on the probable achievement of 100 % of the target. As of March 31, 2026, there wa… |
| XECARE-LLC |
XECARE-LLC |
62%
|
opened an approximately 300,000 square foot facility in New Albany, Ohio. In 2021, this facility began housing a dedicated licensed mail order pharmacy, XeCare, LLC (or “XeCare”), that provides presc… |
| YOURBIO-HEALTH-INC |
YOURBIO-HEALTH-INC |
62%
|
oss profit was $396.8 million for the three months ended March 31, 2026, compared to $430.7 million for the three months ended March 31, 2025, a decrease of $33.9 million, or 8%. Correspondingly, gro… |
| ZAVA-GLOBAL-GMBH |
ZAVA-GLOBAL-GMBH |
62%
|
y pressures or the impact of trade actions may affect the ability of our Subscribers to continue to pay for our products and services, which may also impact the future results of our operations. Inve… |
